Clinical Trial Update: Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial evaluating first-line therapy for metastatic colorectal cancer using FOLFIRI in combination with aflibercept.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Camptosar (irinotecan)
• Leucovorin (folinic acid)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN